Tata India Pharma & HealthCare Fund Regular-Growth
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 1.92% at 30 Oct 2026 02:02 PM
Tata India Pharma & HealthCare Fund Regular-Growth: Mutual Fund Overview
Tata India Pharma & HealthCare Fund Regular-Growth is an Sectoral-Pharma mutual fund with over 10.84 years of performance history. The scheme manages an AUM of ₹1511.48 Cr and has a NAV of ₹31.6903. It is rated '2' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 1.92%.
Fund Details
NAV 31.6903
Sub-Type Sectoral-Pharma
Rating 2
Min. SIP Amount ₹100.0
Fund Age(Year) 10.84
Fund Size(in Crores) 1511.48
Fund Performance
1 Month -4.09%
3 Month -6.04%
6 Month 5.66%
1 Year 1.92%
3 Year 17.35%
5 Year 13.1%
Know This Fund
As on 30 Oct 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (99.72%) Market Cap Small Cap 40.66 Large Cap 30.66 Mid Cap 28.4 Top Sectors Healthcare 88.97 Chemicals 9.52 Consumer Staples 1.23 Top Holding PI Industries 2.59 Navin Fluorine International 1.18 Glaxosmithkline Pharma 0.76 Sumitomo Chemical India 1.38 Prasol Chemicals 0.88 Lupin 3.14 Dr. Lal Pathlabs 1.76 Gillette India 1.23 Natco Pharma 1.51 Dr. Reddy's Laboratories 4.65 Fortis Healthcare 1.95 Rainbow Children's 4.3 Divi's Laboratories 5.68 Zim Laboratories 0.58 Gujarat Fluorochemicals 0.53 Bayer CropScience 2.96 Mankind Pharma 0.77 Max Healthcare Institute 3.71 Sun Pharmaceutical Industries 7.99 Ajanta Pharma 1.63 Manipal Health Enterprises 0.59 Biocon 0.69 Syngene International 2.85 Sai Life Sciences 2.6 Dr. Agarwal's Health Care 0.68 Symbiotec Pharmalab 0.87 Pfizer 2.5 Acutaas Chemicals 1.95 Sanofi Consumer Healthcare India 0.57 Anthem Biosciences 2.57 Cipla 4.22 Healthcare Global Enterprises 5.92 Aster DM Quality Care 1.67 Alkem Laboratories 2.36 Jubilant Pharmova 0 Ipca Laboratories 0.91 Abbott India 5.94 FDC 2.24 Molbio Diagnostics 0.54 Apollo Hospitals Enterprise 4.36 Procter & Gamble Health 2.75 Torrent Pharmaceuticals 3.76
Debt & Others (0.28%) Sector Allocation Repo 0.19 Cash/Net Current Assets 0.09 Debt Credit Ratings Debt Category Others 0.28
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -3.66% Ret 1Y 11.51% Ret 3Y 19.29% Ret 5Y 13.04%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -3.66% Ret 1Y 11.51% Ret 3Y 19.29% Ret 5Y 13.04%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.66% Ret 1Y 11.51% Ret 3Y 19.29% Ret 5Y 13.04%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -2.48% Ret 1Y 15.16% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -2.48% Ret 1Y 15.16% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -2.48% Ret 1Y 15.16% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -3.12% Ret 1Y 9.52% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-Growth Ret 1M -3.9% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-IDCW Ret 1M -3.9% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.9% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -2.11% Ret 1Y 6.92% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.41%
Exit Load 0.25%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Meeta Shetty
Education Ms. Shetty is Bachelor in Economics and CFA Charterholder
Experience Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.
Rajat Srivastava
Education Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Experience Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 28
Date of Incorporation 2015-12-28
Total AUM 224588.36
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
Tata India Pharma & HealthCare Fund Regular-Growth FAQs
How to invest in Tata India Pharma & HealthCare Fund Regular-Growth?
Investing in Tata India Pharma & HealthCare Fund Regular-Growth through Motilal Oswal is simple and completely online. You just need to follow the step-by-step process below to get started in a few minutes.
- Log in to your Motilal Oswal account via the app or website
- Go to the Mutual Funds section
- Search for Tata India Pharma & HealthCare Fund Regular-Growth in the search bar
- Select your preferred investment mode – Lumpsum or SIP
- Enter investment details such as amount and linked bank account
- Complete your KYC, if not already done
- Review and confirm details including fund name, plan type, amount, and bank account
- Make the payment using Net Banking, UPI, or other available options
- Receive transaction confirmation via email or SMS
What is the expense ratio of Tata India Pharma & HealthCare Fund Regular-Growth?
The term expense ratio for Tata India Pharma & HealthCare Fund Regular-Growth or any other mutual fund is the annual fee charged by the fund house for managing your investment scheme. The expense ratio of Tata India Pharma & HealthCare Fund Regular-Growth is 2.41% as of 30 Oct 2026.
What is the NAV of Tata India Pharma & HealthCare Fund Regular-Growth?
The NAV of Tata India Pharma & HealthCare Fund Regular-Growth is ₹31.6903 as of 30 Oct 2026.
What is the AUM of Tata India Pharma & HealthCare Fund Regular-Growth?
The AUM (Assets Under Management) of Tata India Pharma & HealthCare Fund Regular-Growth is the total value of assets managed by the fund at a given time, which is updated regularly. The AUM of Tata India Pharma & HealthCare Fund Regular-Growth is ₹1511.48 Cr as of 30 Oct 2026.
What is the PE and PB ratio of Tata India Pharma & HealthCare Fund Regular-Growth?
The PE ratio of Tata India Pharma & HealthCare Fund Regular-Growth shows how much investors are paying for the fund's underlying earnings, while the PB ratio indicates how the fund's holdings are valued compared to their book value.
Can I invest in SIP and Lump Sum in Tata India Pharma & HealthCare Fund Regular-Growth?
Yes, you can invest in Tata India Pharma & HealthCare Fund Regular-Growth through both SIP (Systematic Investment Plan) and lump sum options, depending on your investment preference and financial goals.
What is the return of Tata India Pharma & HealthCare Fund Regular-Growth in the last 5 years?
The return of Tata India Pharma & HealthCare Fund Regular-Growth in the last 5 years is 13.1%.
What is the minimum SIP investment required in Tata India Pharma & HealthCare Fund Regular-Growth?
The minimum SIP investment in Tata India Pharma & HealthCare Fund Regular-Growth depends on the fund's scheme rules and usually starts at a small amount. For Tata India Pharma & HealthCare Fund Regular-Growth, the minimum SIP amount is ₹100.0.
What is the current NAV of Tata India Pharma & HealthCare Fund Regular-Growth?
The NAV of Tata India Pharma & HealthCare Fund Regular-Growth, as of 30 Oct 2026, is ₹31.6903.
Who manages the Tata India Pharma & HealthCare Fund Regular-Growth?
The fund managers responsible for Tata India Pharma & HealthCare Fund Regular-Growth are:
- Meeta Shetty
- Rajat Srivastava